Earnings calendar/ARWR
Arrowhead Pharmaceuticals, Inc. (ARWR)
Pre-earnings consensus targets and post-earnings beat/miss — standardized metrics from the earnings calendar. No narrative, no price targets.
Pre-earnings
Consensus targets for the next print, plus how the business has been running.
Next report
Nov 24, 2026
Consensus estimate row
EPS target
$-1.52
Street estimate
Revenue target
$71.8M
Street estimate
Trailing EPS (avg 4Q)
$-0.56
Beat rate last 4: 25%
Latest EPS YoY
-7.9%
vs 2025-08-07
Latest revenue YoY
+171.0%
How results look so far
Trailing revenue (avg 4Q)
$167.4M
Printed quarters
EPS beat rate (4Q)
25%
Share of quarters that beat EPS est.
Post-earnings
Did the company hit the target? Actual vs estimate and surprise.
Last print
Aug 4, 2026
EPS miss
EPS actual / est
$-1.36 / $-1.28
-6.3%
Revenue actual / est
$75.3M / $44.2M
+70.4%
Result
Below target
Based on EPS vs consensus
Earnings history
Estimate vs actual and surprise % by print date
| Date | EPS est | EPS act | EPS surprise | Rev est | Rev act | Rev surprise |
|---|---|---|---|---|---|---|
| 11/24/2026upcoming | $-1.52 | Pending | — | $71.8M | Pending | — |
| 8/4/2026 | $-1.28 | $-1.36 | -6.3% | $44.2M | $75.3M | +70.4% |
| 5/11/2026upcoming | $-1.04 | Pending | — | $71.5M | Pending | — |
| 5/7/2026 | $-1.09 | $-0.93 | +14.7% | $73.8M | $73.7M | -0.1% |
| 2/9/2026upcoming | $0.70 | Pending | — | $200.8M | Pending | — |
| 2/5/2026 | $0.60 | $0.22 | -63.3% | $213.9M | $264.0M | +23.4% |
| 11/25/2025 | $-0.11 | $-0.18 | -61.3% | $175.3M | $256.5M | +46.3% |
| 8/7/2025 | $-0.94 | $-1.26 | -34.0% | $154.1M | $27.8M | -82.0% |
| 5/12/2025 | $-0.06 | $2.75 | +4683.3% | $116.3M | $542.7M | +366.8% |
| 2/10/2025 | $-0.42 | $-1.39 | -231.0% | $19.1M | $2.5M | -86.9% |
| 11/26/2024 | $-1.05 | $-1.38 | -31.4% | $55.1M | $3.6M | -93.6% |
| 8/8/2024 | $-0.58 | $-1.38 | -137.9% | $69.7M | Pending | — |
| 5/9/2024 | $-0.06 | $-1.02 | -1600.0% | $63.9M | Pending | — |
| 2/6/2024 | $-0.78 | $-1.24 | -59.0% | $29.5M | $3.6M | -88.0% |
| 11/29/2023 | $-0.70 | $-1.03 | -47.1% | $50.7M | $16.1M | -68.3% |
| 8/7/2023 | $-0.58 | $-0.96 | -65.5% | $59.8M | $15.8M | -73.5% |
| 5/2/2023 | $-0.64 | $0.45 | +170.3% | $45.5M | $146.3M | +221.6% |
| 2/6/2023 | $1.14 | $-0.39 | -134.2% | $162.5M | $62.5M | -61.5% |
| 11/28/2022 | $-0.57 | $-0.81 | -42.1% | $50.3M | $31.6M | -37.2% |
| 8/4/2022 | $-0.45 | $-0.68 | -51.1% | $45.8M | $32.4M | -29.2% |
| 5/10/2022 | $-0.08 | $0.41 | +612.5% | $122.1M | $151.8M | +24.3% |
| 2/2/2022 | $-0.22 | $-0.60 | -172.7% | $47.8M | $27.4M | -42.6% |
| 11/22/2021 | $-0.11 | $-0.61 | -478.2% | $37.2M | $38.3M | +2.8% |
| 8/5/2021 | $-0.08 | $-0.29 | -262.5% | $37.5M | $45.9M | +22.3% |
| 5/4/2021 | $-0.09 | $-0.26 | -188.9% | $37.7M | $32.8M | -13.0% |
| 2/4/2021 | $1.00 | $-0.20 | -120.0% | $79.5M | $21.3M | -73.2% |
| 11/23/2020 | $0.34 | $-0.48 | -241.2% | $41.2M | $7.6M | -81.5% |
| 8/5/2020 | $-0.07 | $-0.13 | -85.7% | $25.3M | $27.4M | +8.3% |
| 5/7/2020 | $-0.11 | $-0.20 | -81.8% | $15.9M | $23.5M | +48.1% |
| 2/5/2020 | $-0.01 | $-0.03 | -322.5% | $9.8M | $29.5M | +200.0% |
| 11/25/2019 | $0.16 | $0.11 | -31.3% | $63.0M | $43.3M | -31.2% |
| 8/5/2019 | $0.29 | $0.21 | -27.6% | $59.0M | $42.7M | -27.6% |
| 5/8/2019 | $0.19 | $0.24 | +26.3% | $38.1M | $48.1M | +26.3% |
| 2/7/2019 | $0.54 | $0.13 | -75.9% | $144.0M | $34.7M | -75.9% |
| 12/11/2018 | $-0.17 | $-0.12 | +29.4% | $10.3M | $11.3M | +9.0% |
| 8/7/2018 | $-0.19 | $-0.18 | +5.3% | $730,000 | $727,375 | -0.4% |
| 5/8/2018 | $-0.18 | $-0.18 | 0.0% | $650,000 | $650,125 | +0.0% |
| 2/9/2018 | $-0.18 | $-0.18 | 0.0% | $3.1M | $3.5M | +12.5% |
| 12/12/2017 | $-0.12 | $-0.14 | -16.7% | $5.8M | $8.7M | +50.1% |
| 8/3/2017 | $-0.13 | $-0.07 | +46.2% | $18.7M | $9.3M | -50.0% |
| 5/3/2017 | $-0.12 | $-0.08 | +33.3% | $13.5M | $9.0M | -33.4% |
| 2/6/2017 | $-0.18 | $-0.17 | +5.6% | $5.1M | $4.4M | -15.1% |
| 12/14/2016 | $-0.33 | $-0.31 | +6.1% | $17,647.06 | $31,250 | +77.1% |
| 8/9/2016 | $-0.37 | $-0.32 | +13.5% | $46,250 | $39,583 | -14.4% |